Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological Superiority of Two-Dose Butantan-DV Regimen and Manufacturing Facility Transition in Children and Adolescents
NCT07712926Phase 3Not yet recruiting
- Sponsor
- Instituto Butantan
- Start
- Feb 2027
- Primary completion
- Feb 2028
01
Overview
A Phase 3 trial of Butantan-DV in dengue fever, sponsored by Instituto Butantan. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
Butantan-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT07712926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07712926.